Toulouse-based Tesalys SAS treats infectious medical waste on site using steam sterilization and grinding systems.
Founded in 2012 and headquartered in Toulouse, France, Tesalys SAS develops systems for managing infectious waste, including its STERIPLUS and STERISHRED products. The equipment grinds and decontaminates waste with steam sterilization at 135°C for on-site treatment in hospitals and laboratories. In September 2019 the company closed a Series B round of EUR 4 million from IXO Private Equity and Sigma Gestion, and it has executed 5 deals in total. Tesalys reports serving clients in over 67 countries.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in